Dr. Oleg Gligich
Claim this profileMount Sinai Medical Center
Studies Non-Small Cell Lung Cancer
Studies Cancer
9 reported clinical trials
26 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
PD-L1 positive
2Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Oleg Gligich is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Bemcentinib + Pembrolizumab + Chemotherapy
for Non-Small Cell Lung Cancer
The primary purpose of this study is to determine the safety and tolerability of the combination of bemcentinib with chemo-immunotherapy (CIT) to identify the recommended phase 2 dose (RP2D) when administered as first line (1L) treatment in participants with locally advanced (Stage IIIb/IIIC) or metastatic (Stage IV) non-squamous NSCLC with no actionable mutations and to determine the anti-tumor activity of the combination of bemcentinib with CIT when administered as 1L treatment in participants with locally advanced (Stage IIIb/IIIc) or metastatic (Stage IV) non-squamous NSCLC with serine/threonine kinase 11 (STK11) mutation and no actionable mutations.
Recruiting1 award Phase 1 & 24 criteria
More about Oleg Gligich
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Oleg Gligich has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- AlloStim
- Bemcentinib
- Atezolizumab
Breakdown of trials Oleg Gligich has run
Non-Small Cell Lung Cancer
Cancer
Recurrence
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Oleg Gligich specialize in?
Oleg Gligich focuses on Non-Small Cell Lung Cancer and Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Oleg Gligich currently recruiting for clinical trials?
Yes, Oleg Gligich is currently recruiting for 5 clinical trials in Miami Beach Florida. If you're interested in participating, you should apply.
Are there any treatments that Oleg Gligich has studied deeply?
Yes, Oleg Gligich has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Oleg Gligich?
Apply for one of the trials that Oleg Gligich is conducting.
What is the office address of Oleg Gligich?
The office of Oleg Gligich is located at: Mount Sinai Medical Center, Miami Beach, Florida 33140 United States. This is the address for their practice at the Mount Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.